Venetoclax in Relapsed/Refractory Acute Myeloid Leukemia: Are Supporting Evidences Enough?

SIMPLE SUMMARY: Venetoclax (VEN) is a potent oral inhibitor of the anti-apoptotic molecule BCL2, approved for adults with chronic lymphocytic leukemia (CLL), and recently for naïve acute myeloid leukemia (AML) unfit for intensive chemotherapy. Therefore, VEN is not approved for relapsed/refractory (...

Descripción completa

Detalles Bibliográficos
Autores principales: Brancati, Serena, Gozzo, Lucia, Romano, Giovanni Luca, Vetro, Calogero, Dulcamare, Ilaria, Maugeri, Cinzia, Parisi, Marina, Longo, Laura, Vitale, Daniela Cristina, Di Raimondo, Francesco, Drago, Filippo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750253/
https://www.ncbi.nlm.nih.gov/pubmed/35008186
http://dx.doi.org/10.3390/cancers14010022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750253/
https://www.ncbi.nlm.nih.gov/pubmed/35008186
http://dx.doi.org/10.3390/cancers14010022

Ejemplares similares